23andMe (OTCMKTS:MEHCQ) Upgraded at Wall Street Zen

Posted by Editorial Team on Aug 11th, 2025

23andMe (OTCMKTS:MEHCQ – Get Free Report) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Saturday.

23andMe Stock Down 4.8%

23andMe stock opened at $4.00 on Friday.

About 23andMe

(Get Free Report)

23andMe Inc is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc, formerly known as VG Acquisition Corp., is headquartered in Sunnyvale, CA.

Five stocks we like better than 23andMe
High Dividend REITs: Are They an Ideal Way to Diversify?
3 Dividend Stocks Raising Payouts—and Backing It Up With Results
How Can Investors Benefit From After-Hours Trading
3 Stocks With Monopoly Power—and Minimal Competition
Comparing and Trading High PE Ratio Stocks
Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact?

Receive News & Ratings for 23andMe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 23andMe and related companies with MarketBeat.com's FREE daily email newsletter.

23andMe (OTCMKTS:MEHCQ) Upgraded at Wall Street Zen

23andMe Stock Down 4.8%

About 23andMe

Read More

You might be interested in: